Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Behind every public health achievement are extraordinary scientists, researchers and advocates. For the past 21 years at the Sabin Vaccine Institute (Sabin), we have honored these distinguished leaders through the Albert B.
With the slogan “Immunization for a healthy future. Know, Check, Protect” WHO reminds us this week that vaccines prevent 2-3 million deaths each year. Just imagine this: 2 to 3 million lives. This equals the populations of countries like Mongolia or Botswana.
This post is part of our World Immunization Week blog series. Stay tuned for more blogs highlighting the benefits of immunization and the work Sabin is doing to support immunization programs worldwide.